Fiorentino, Francesca, Beatrice Canali, Paolo Morelli, and Federica Demma. 2023. “Brentuximab Vedotin in Combination With Doxorubicin, Vinblastine and Dacarbazine for First-Line Treatment of Stage IV HL: Cost Impact on Subsequent Lines in Italy”. AboutOpen 10 (1):6-12. https://doi.org/10.33393/ao.2023.2486.